FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Hologic’s MRSA Assay Receives CE Mark in Europe

July 6, 2018
A A

Hologic’s Panther Fusion MRSA assay received CE Mark approval in Europe, expanding the Panther Fusion system’s menu of assays.

The MRSA assay detects and differentiates between Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) DNA by analyzing nasal samples.

The assay is capable of identifying empty cassette variants and a broad range of strains, including the Bengal Bay clone.

View today's stories